VIOL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11,260 KRW | +2.36% |
|
+13.97% | +32.47% |
| 25/03 | Sihuan Pharmaceutical's RF Device Wins Registration Approval in China | MT |
| 2023 | SULLIVAN WILL DISCUSS EFFORTS TO REIN IN 'EXTREMIST SETTLER VIOL… | RE |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Capitalization 1 | 1,23,986 | 1,87,480 | 6,50,186 | 6,50,186 | - |
| Enterprise Value (EV) 2 | 124 | 156.3 | 490.1 | 577.4 | 543.4 |
| P/E ratio | 29.8 x | 16.5 x | 23 x | 23.2 x | 17.4 x |
| Yield | - | - | 0.09% | 0.13% | 0.15% |
| Capitalization / Revenue | - | 6.03 x | 11.5 x | 10.6 x | 7.71 x |
| EV / Revenue | - | 5.02 x | 11.5 x | 9.46 x | 6.44 x |
| EV / EBITDA | - | 11.6 x | 20.9 x | 18 x | 12 x |
| EV / FCF | - | 14.5 x | 33 x | 24.4 x | 18.2 x |
| FCF Yield | - | 6.88% | 3.03% | 4.1% | 5.48% |
| Price to Book | - | 4.81 x | 11.1 x | 7.66 x | 5.46 x |
| Nbr of stocks (in thousands) | 54,740 | 58,133 | 57,743 | 57,743 | - |
| Reference price 3 | 2,265 | 3,225 | 11,260 | 11,260 | 11,260 |
| Announcement Date | 15/03/22 | 07/02/23 | 01/02/24 | - | - |
1KRW in Million2KRW in Billions3KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net sales 1 | - | 31.11 | 42.52 | 61.05 | 84.37 |
| EBITDA 1 | - | 13.52 | 23.41 | 32.05 | 45.3 |
| EBIT 1 | - | 12.92 | 22.31 | 31.35 | 44.77 |
| Operating Margin | - | 41.53% | 52.48% | 51.35% | 53.06% |
| Earnings before Tax (EBT) 1 | - | 13.78 | 26.07 | 32.55 | 45.05 |
| Net income 1 | 4.437 | 11.47 | 21.56 | 27.85 | 36.25 |
| Net margin | - | 36.88% | 50.71% | 45.62% | 42.97% |
| EPS 2 | 76.00 | 196.0 | 369.0 | 485.7 | 646.7 |
| Free Cash Flow 3 | - | 10,746 | 18,167 | 23,700 | 29,800 |
| FCF margin | - | 34,543.86% | 42,085.59% | 38,819.37% | 35,322.01% |
| FCF Conversion (EBITDA) | - | 79,470.53% | 76,733.54% | 73,946.96% | 65,783.66% |
| FCF Conversion (Net income) | - | 93,665.7% | 83,127.42% | 85,098.74% | 82,206.9% |
| Dividend per Share 2 | - | - | 10.00 | 15.00 | 16.67 |
| Announcement Date | 15/03/22 | 07/02/23 | 01/02/24 | - | - |
1KRW in Billions2KRW3KRW in Million
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 10.57 | 9.475 | 10.62 | 11.15 | 12.22 | 9.65 | 14.6 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | - | 4.805 | 4.47 | 5.693 | 6.1 | 6.324 | 4.9 | 7.5 |
| Operating Margin | - | 45.48% | 47.18% | 53.59% | 54.71% | 51.73% | 50.78% | 51.37% |
| Earnings before Tax (EBT) 1 | - | 3.656 | 4.947 | 8.525 | 6.4 | 7.2 | - | - |
| Net income 1 | 3.943 | 2.803 | 4.151 | 7.205 | - | 5.41 | 4.4 | 6.46 |
| Net margin | - | 26.53% | 43.81% | 67.83% | - | 44.26% | 45.6% | 44.25% |
| EPS | 67.00 | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 11/11/22 | 07/02/23 | 11/05/23 | 10/08/23 | - | - | - | - |
1KRW in Billions
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - |
| Net Cash position 1 | - | 31.2 | 51 | 72.7 | 107 |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow 2 | - | 10,746 | 18,167 | 23,700 | 29,800 |
| ROE (net income / shareholders' equity) | - | 35.1% | 44.9% | 39.5% | 36.3% |
| ROA (Net income/ Total Assets) | - | 30.8% | 39.4% | 34.8% | 32.9% |
| Assets 1 | - | 37.22 | 55.47 | 80.14 | 110.2 |
| Book Value Per Share 3 | - | 670.0 | 1,014 | 1,470 | 2,064 |
| Cash Flow per Share 3 | - | - | 367.0 | 505.0 | 665.0 |
| Capex 1 | - | 0.48 | 1 | 0.7 | 1.97 |
| Capex / Sales | - | 1.55% | 2.32% | 1.15% | 2.33% |
| Announcement Date | 15/03/22 | 07/02/23 | 01/02/24 | - | - |
1KRW in Billions2KRW in Million3KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
11,260
KRW
Average target price
11,500
KRW
Spread / Average Target
+2.13%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +32.47% | 465M | |
| +11.50% | 221B | |
| +9.21% | 186B | |
| +14.78% | 137B | |
| +27.59% | 109B | |
| -0.04% | 63.09B | |
| +13.73% | 52.68B | |
| +4.86% | 50.86B | |
| +7.67% | 42.53B | |
| +7.54% | 37.76B |
- Stock Market
- Equities
- A335890 Stock
- Financials VIOL Co., Ltd.